| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.37 | 0.06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.07 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |